Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).
This page lists clinical trials related to Giardia Infections from the ClinicalTrials.gov database.
Trial Summary
- Total studies: 14
- Recruiting: 1
- Active, not recruiting: 1
- Completed: 7
- Other: 5
Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.
Recruiting Trials
NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Institut Pasteur du Cambodge |
| Enrollment | 10000 |
| Study Type | OBSERVATIONAL |
| Conditions | Dengue; Chikungunya; Zika Virus Infection; Japanese Encephalitis; West Nile Virus |
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics. This knowledge gap hinders the design of effective prevention and control strategies.
RACSMEI will improve understanding across multiple pathogens using a multidisciplinary One He…
Active, Not Recruiting
NCT04827537 — Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone
| Status | Active, not recruiting |
| Phase | Phase 2 / Phase 3 |
| Sponsor | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan |
| Enrollment | 200 |
| Study Type | INTERVENTIONAL |
| Conditions | Giardia Lamblia Infection |
| Interventions | ; ; |
20-hydroxyecdysone is an ecdysteroid hormone found in invertebrates and plants. 20-hydroxyecdysone exhibits a broad range of biological properties in various in vitro and in vivo models, including anabolic, antioxidant, anti-inflammatory, immunomodulatory, anti-obesity and antidiabetic activities, in addition to acting as neuroprotective and hepatoprotective agent. Ecdysteroids are widely used …
Not Yet Recruiting
NCT06533696 — A Comparison of Microscopy and Enzyme Linked Immunosorbent Assay for Diagnosis of Giardia Lamblia in Children, Sohag
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Sohag University |
| Enrollment | 94 |
| Study Type | OBSERVATIONAL |
| Conditions | Giardia Lamblia Infection |
The present study was done to evaluate the efficacy of Human anti Giardia lamblia antibody (ELISA) kitst in comparison to direct microscopy in the diagnosis of G. lamblia in stool specimens from immunocompetent and immunocompromised children with diarrhea and other gastrointestinal symptoms.
Completed Trials
NCT00607074 — Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh
| Status | Completed |
| Phase | N/A |
| Sponsor | University of Cambridge |
| Enrollment | 410 |
| Study Type | INTERVENTIONAL |
| Conditions | Giardiasis |
| Interventions | ; ; |
This longitudinal study aimed to assess whether regular anti-Giardia and antihelmintic treatment improved growth and small intestinal mucosal function of rural Bangladeshi infants.
NCT00456729 — Malabsorption as a Cause of Iron Treatment Failure in Infants
| Status | Completed |
| Phase | N/A |
| Sponsor | HaEmek Medical Center, Israel |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Iron Deficiency; Malabsorption |
| Interventions | ; |
Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.
NCT00739258 — Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
| Status | Completed |
| Phase | N/A |
| Sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital |
| Enrollment | 700 |
| Study Type | OBSERVATIONAL |
| Conditions | HIV Infections |
It is difficult to detect the intestinal protozoal infections among the HIV-infected persons or travelers diarrhea by using the traditional microscopy or staining methods. The purpose of this study aimed at finding out the appropriate diagnostic methods and the infection rate of the intestinal protozoa, including the Entamoeba, Cryptosporidium and Giardia among the HIV-infected persons by using…
NCT00860236 — Giardia Induced Fatigue and Functional Gastrointestinal Diseases
| Status | Completed |
| Phase | Phase 4 |
| Sponsor | University of Bergen |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Chronic Fatigue Syndrome |
| Interventions | ; |
A giardiasis outbreak in Bergen has given us the opportunity to approach two basic research questions of national and global importance:
- Studying the pathoimmunology of giardiasis in a natural setting, and following the genetic and immunological responses leading to recovery or persistent disease and sequelae.
- Studying the two disease entities FGID and CFS when induced by acute giardiasi a…
NCT02105714 — Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
| Status | Completed |
| Phase | N/A |
| Sponsor | Swiss Tropical & Public Health Institute |
| Enrollment | 2800 |
| Study Type | OBSERVATIONAL |
| Conditions | Soil-transmitted Helminthiasis; Schistosomiasis; Strongyloidiasis; Shigellosis; Intestinal Salmonellosis |
| Interventions | ; ; |
NIDIAG is an international collaboration on integrated diagnosis-treatment platforms, funded by the European Commission (EC). NIDIAG aims to develop an improved, patient-centred system for delivering primary health care in resource-constrained settings. NIDIAG will investigate three clinical syndromes, namely (i) persistent digestive disorders, (ii) persistent fever and (iii) neurological disor…
NCT02736968 — Auranofin for Giardia Protozoa
| Status | Completed |
| Phase | Phase 2 |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Enrollment | 93 |
| Study Type | INTERVENTIONAL |
| Conditions | Amoebic Dysentery; Giardiasis |
| Interventions | ; |
This is a phase IIa, randomized, placebo-controlled, single-blinded superiority treatment study in males and non-pregnant females, 18 to 65 years of age who are in good health. This study is designed to compare placebo to once daily doses of 6mg auranofin for adults with amebiasis or giardiasis. A sample size of 68 subjects enrolled with amebiasis (34 per arm) and 68 with giardiasis (34 per arm…
NCT03490435 — Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian Province in Poland
| Status | Completed |
| Phase | N/A |
| Sponsor | Nicolaus Copernicus University |
| Enrollment | 22 |
| Study Type | OBSERVATIONAL |
| Conditions | Intestinal Disease, Parasitic; Chronic Disease |
| Interventions |
The goal of the proposed study is to assess the prevalence of intestinal parasitic diseases in adults and children. These invasions are included to “dirty hand diseases” (per os invasions), therefore it applies mainly preschool children.
Other (Terminated)
NCT00001162 — Parasitic Infections of the Gastrointestinal Tract
| Status | Terminated |
| Phase | N/A |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Enrollment | 150 |
| Study Type | OBSERVATIONAL |
| Conditions | Amebiasis; Cryptosporidiosis; Giardiasis; Parasitic Disease; Parasitic Intestinal Disease |
This protocol offers diagnosis and standard medical treatment for various parasitic gastrointestinal infections. Gastrointestinal parasites are either worms (helminths) or one-celled animals called protozoans which live in the human intestines. Often, parasitic infections do not cause illness. In these cases, drug treatment is not indicated, because treatment can have adverse side effects. Pati…
Other (Unknown)
NCT01646411 — 300 Antibody Diagnostic Test Kit
| Status | Unknown |
| Phase | N/A |
| Sponsor | The Plasma Source |
| Enrollment | 300 |
| Study Type | OBSERVATIONAL |
| Conditions | Acute Bacterial Infections; Acute Viral Infections |
For the development of a Point of Care IVD test kit for acute phase disease detection against a variety of bacterial and viral infections. Phase one includes 100 clinical diagnosed positive and 200 clinically “normal” serum and whole blood matched specimens for specificity and sensitivity determination for each marker. The positive samples must be IgM positive using any FDA cleared ELISA test k…
NCT02942485 — Treatment of Giardia Lamblia Infections in Children
| Status | Terminated |
| Phase | Phase 4 |
| Sponsor | Helsinki University Central Hospital |
| Enrollment | 8 |
| Study Type | INTERVENTIONAL |
| Conditions | GIARDIASIS |
| Interventions | ; |
This study investigates the efficacy and safety of rectally administered metronidazole for pediatric Giardia lamblia infection, as well as the acceptance of this treatment regimen by patients/caregivers. The investigators hypothesize that rectal metronidazole is non-inferior to single-dose of oral tinidazole and will cure at least 72% of patients, a well as will be tolerated as good as tinidazole.
NCT04778280 — Vitamin D Estimation With Giardia Lamblia Infections
| Status | Unknown |
| Phase | N/A |
| Sponsor | Sohag University |
| Enrollment | 192 |
| Study Type | OBSERVATIONAL |
| Conditions | Giardia Lamblia Infection |
investigators will take stool and blood samples from two groups of humans :-
1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators make estimation for vitamin D in both groups then investigators try to find if there is relation between vitamin D level and Giardia lamblia infections